SCHEMBL20140502

SCHEMBL20140502

Cc1c(CN2CCN(c3ncccc3Cl)CC2)cc(C(=O)N2CCN(c3ccc(F)cc3)CC2C)n1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 3/20 0.57
RPTOR Q8N122 3/20 0.57
MLST8 Q9BVC4 3/20 0.57
TRPV1 Q8NER1 5/20 0.46
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
HSP90AA1 P07900 1/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CHRM1 P11229 5/20 0.42
CHRM4 P08173 4/20 0.42
ALDH1A1 P00352 1/20 0.39
GFER P55789 1/20 0.39
CXCR3 P49682 1/20 0.38
CHRM2 P08172 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20140499 1.00 MTOR (0.57) MTORRPTORMLST8TRPV1KDM4E
SCHEMBL20142006 0.92 MTOR (0.60) MTORRPTORMLST8TRPV1CHRM1
SCHEMBL20142009 0.92 MTOR (0.60) MTORRPTORMLST8TRPV1CHRM1
SCHEMBL20140493 0.90 MTOR (0.56) MTORRPTORMLST8TRPV1KDM4E
SCHEMBL20140492 0.90 MTOR (0.56) MTORRPTORMLST8TRPV1KDM4E
SCHEMBL20159012 0.88 MTOR (0.72) MTORRPTORMLST8KDM4ERAB9A
SCHEMBL20142049 0.87 MTOR (0.71) MTORRPTORMLST8KDM4ELMNA
SCHEMBL20140249 0.86 MTOR (0.60) MTORRPTORMLST8TRPV1CHRM1
SCHEMBL20140252 0.86 MTOR (0.60) MTORRPTORMLST8TRPV1CHRM1
SCHEMBL20140657 0.85 MTOR (0.68) MTORRPTORMLST8KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 US disclosed
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
WO-2018089493-A1 PYRROLE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.